Telemedicine for living kidney donor candidates
Treatments studied
This study tests whether telemedicine visits can effectively support people who want to donate a kidney. It aims to make the donation process easier and more convenient for California residents.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must live in the state of California.
- You must be registered as a living kidney donor candidate at UC Irvine Medical Center.
- You must not have any health condition that prevents kidney donation, like heart disease or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a way to spread information on how to register as a live organ donor using social media. You may be contacted to help identify potential live kidney or liver donors, if you fit the study’s basic requirements.
This study tests a combined approach for kidney transplant patients: standard living-donor kidney transplant plus an added “stem cell” component taken from the same sibling donor. It aims to improve transplant outcomes by trying to better control the immune response and reduce complications.
This study tests a program that combines digital tools and in-person guidance to help people get a kidney transplant from a living donor. It aims to increase the number of living donor transplants.
This study tests a mobile app that provides information and support to people considering living kidney donation. It may help you make a more informed decision about donation.
This Phase 2 trial studies a treatment using immune cells made from your living donor, given around the time of kidney transplant. It aims to improve transplant safety and outcomes by adjusting the immune response to the new kidney.
This trial tests a new way to help your body accept the transplanted kidney without needing as many strong anti-rejection drugs. It uses special cells from your living donor, which may lower the risk of rejection and reduce side effects.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.